CHLORURE DE POTASSIUM POUR INJECTION - CONCENTRÉ Solution

Land: Canada

Språk: fransk

Kilde: Health Canada

Aktiv ingrediens:

Chlorure de potassium

Tilgjengelig fra:

OMEGA LABORATORIES LIMITED

ATC-kode:

B05XA01

INN (International Name):

POTASSIUM CHLORIDE

Dosering :

200mEq

Legemiddelform:

Solution

Sammensetning:

Chlorure de potassium 200mEq

Administreringsrute:

Intraveineuse

Enheter i pakken:

100ML

Resept typen:

Spécialité médicale

Terapeutisk område:

REPLACEMENT PREPARATIONS

Produkt oppsummering:

Numéro de groupe d'ingrédients actifs (GIA) :0100273047; AHFS:

Autorisasjon status:

APPROUVÉ

Autorisasjon dato:

2018-08-13

Preparatomtale

NOM DU PRODUIT / PRODUCT NAME:
NUMÉRO DU PRODUIT/PRODUCT NUMBER:
N
O
CODE À BARRES / BARCODE NO.:
CLIENT
ÉPREUVES DE L’IMPRIMEUR / VENDOR’S PROOF
DATE:
INITIALES:
SPÉCIFICATIONS
TYPE ET POIDS DE PAPIER / PAPER TYPE AND WEIGHT:
DIMENSIONS (MM): À PLAT / FLAT:
PLIÉ / FOLDED:
POINTS DE COLLE / GLUE SPOTS:
FEUILLET PLIÉ / FOLDED LEAFLET:
LFLT POTASSIUM CHLORIDE 100ML
C00P1071_V02
712
LABORATOIRES OMEGA
60M (30#) OFFSET
235 X 347
118 X 50
N/A
ANGLAIS/ENGLISH VISIBLE
2021-11-19
RECTO / FRONT
C00P1071_V02
POTASSIUM CHLORIDE
FOR INJECTION CONCENTRATE
USP Standard
200 MEQ/100 ML (2 MEQ/ML),
14.9% (149 MG/ML),
4.00 MOSM/ML
ELECTROLYTE REPLENISHER
PHARMACY BULK PACKAGE FOR PREPARING SOLUTION
FOR INTRAVENOUS (IV) INFUSION
AFTER DILUTION ONLY
" THIS CONCENTRATE MUST BE DILUTED INTO BULK SOLUTION
BEFORE USE.
" THIS CONCENTRATE IS NOT FOR DIRECT INJECTION OR INFUSION.
" THIS CONCENTRATE IS NOT
TO BE ADDED DIRECTLY TO AN
INFUSION BAG OR INFUSION LINE.
" THIS CONCENTRATE IS NOT FOR USE IN PATIENT CARE AREAS.
" THIS CONCENTRATE MUST BE USED WITHIN 24 HOURS AFTER
THE FIRST USE,
AND ANY UNUSED PORTION MUST BE DIS-
CARDED. DO NOT RESTERILIZE.
" DO NOT USE IF SOLUTION IS HAZY, DISCOLORED, HAS PARTICU-
LATE MATTER OR IS LEAKING.
WARNING
This is a highly concentrated solution and it is commonly
diluted to 5L or 10L.
DIRECTIONS
This concentrate is for use in Pharmacy Admixture Programs
only and it is not for use in patient care areas. This concen-
trate is not for direct injection or infusion. This concentrate
is not
to be added directly to an infusion bag or infusion
line.
The contents of 100mL should be diluted to a total volume
of 5L or 10L with dextrose 5% or other isotonic intravenous
solution. The resultant solution should be labelled properly
for administration only by intravenous infusion and mon-
itoring is recommended.
The 100mL vial
is single-use,
non-pyrogenic and preserva-
tive-free.
The contents of
this concentrate must
be used
within 24 hours after the first use. Discard unused portion.
Do not
use if
solution is